mcas and semaglutide A newly published case series reports that GLP-1 receptor agonists (like tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or Mast Cell Activation Syndrome (MCAS)

Dihexa's preclinical design emphasized brain penetration, and animal studies showed CNS effects

Chen and his colleagues demonstrated that BMSCs-Exos through exosomal circ-ITCH could alleviate ferroptosis in the diabetes mellitus model and improve the angiogenesis ability of HUVECs [195]

SFTPA1, Surfactant Protein A1

GLP-1 receptor activation has been linked to reduced anxiety and depression. Even for those who merely want to lose a few pounds, microdosing has its advantages, because the regular FDA starting measure can produce unpleasant side effects like burping, nausea and indigestion, along with muscle atrophy and the dreaded saggy or drawn Ozempic face that comes from rapid weight loss

While effective, both GLP-1 agonists and SGLT2 inhibitors should complement lifestyle interventions, including diet, exercise, and weight management